Novartis Posts Q4 Earnings and Sales Beat, Shares Gain

Swiss pharma giant Novartis AG (NVS) reported better-than-expected results for the fourth quarter of 2024. Core earnings (excluding one-time charges) of $1.98 per share easily beat the Zacks Consensus Estimate of$1.81 and were up from $1.53 reported a year ago. The year-over-year growth was driven by strong growth in sales.Revenues of$13.15 billion climbed 15% from the year-ago reported figure. On a constant currency basis, sales increased 16%, driven by the momentum in Entresto, Kesimpta, Kisqali, Cosent ...